<DOC>
	<DOCNO>NCT00427609</DOCNO>
	<brief_summary>The purpose study determine efficacy Bicillin L-A , administer intramuscularly dose 2.4 million unit every three ( 3 ) week , treatment chronic , plaque-type psoriasis unresponsive topical medication systemic therapy contraindicate .</brief_summary>
	<brief_title>Bicillin L-A v Placebo Treatment Chronic , Plaque-Type Psoriasis Unresponsive Topical Medications</brief_title>
	<detailed_description>Psoriasis chronic , inflammatory skin disorder commonly manifest well-demarcated , erythematous and/or scale plaque elbow , knee , scalp , trunk . Psoriasis common disease overall incidence 1-3 % general population . The estimated prevalence varies 1-2 % . There significant geographical variability low incidence disease around equator increase towards pole . Psoriasis consider autoimmune disease mediate activated T-cells , release proinflammatory cytokine , predominately TNF-a IFN-y . The key role T-cells pathogenesis psoriasis support report beneficial effect specific T cell target therapy include cyclosporin A certain recently market immune response modifier . While disease pathogenesis still completely understood , factor may trigger worsen psoriasis systematically study well described medical literature . Psychological stress , mechanical trauma skin , certain medication Streptococcus strain common disease trigger . It first report 1916 onset psoriasis often precede throat infection hemolytic streptococci role M-protein positive beta hemolytic streptococci trigger guttate psoriasis confirm subsequent study . Exacerbation chronic plaque type psoriasis report association tonsillitis retrospective study . Moreover , high frequency remission tonsillectomy antibiotic treatment document .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Penicillin G Benzathine</mesh_term>
	<mesh_term>Penicillin G</mesh_term>
	<mesh_term>Penicillin G Procaine</mesh_term>
	<criteria>Male female 18 50 year age ( onset age 40 ) Presence chronic plaque type psoriasis unresponsive treatment topical preparation extensive enough consider appropriateness systemic therapy Guttate form psoriasis Nonresponsive treatment worsen preexist psoriasis With exception skin disease , good general state health base complete medical history , blood test urine analysis . Females must negative urine pregnancy test willing take additional measure keep become pregnant course study No systemic prescription medication control psoriasis within past 30 day Free topical antipsoriatic preparation duration study exception emollients moisturizers Pustular form psoriasis , either localize generalize Generalized Erythrodermic psoriasis Only palmoplantar psoriasis Only scalp psoriasis Only nail psoriasis Only inverse psoriasis Diabetes impair glucose tolerance History recurrent yeast infection History hypersensitivity Penicillin History severe adverse drug reaction Pregnancy Lactation HIV/AIDS History renal disease History liver disease History presence alcohol and/or drug dependence abuse History significant psychiatric illness History allergy , asthma , allergic rhinitis , urticaria subject research trial , least 30 day prior begin study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Treatment</keyword>
	<keyword>Psoriasis</keyword>
	<keyword>efficacy</keyword>
	<keyword>Bicillin</keyword>
</DOC>